Impact of the human leucocyte antigen (HLA)-B leader peptide dimorphism and HLA-A expression on outcomes of stem cell transplantation for sickle cell disease.

Barbara CappelliGraziana M ScigliuoloWahid BoukouaciHanadi RafiiFernanda VoltChantal KenzeyKarina T MaioChristian ChabannonSelim CorbaciogluVanderson RochaAnnalisa RuggeriEliane GluckmanRyad Tamouza

Published in: British journal of haematology (2021)

Keyphrases

stem cell transplantation
sickle cell disease
high dose
endothelial cells
poor prognosis
induced pluripotent stem cells
pluripotent stem cells
low dose
type diabetes
binding protein
metabolic syndrome
adipose tissue
glycemic control